Back to overview
d’Young 2008
Back to overview
d'Young AI. Domiciliary application of CryoCuff in severe haemophilia: qualitative questionnaire and clinical audit. Haemophilia. 2008 Jul;14(4):823-7.
Design: Qualitative questionnaire study.
Subjects: 12 patients, either with severe haemophilia A/B or with VWD (von Willebrand's disease) Methods: Patients were asked to use the Aircast Cryo/Cuff device as part of the PRICE regime immediately following the onset of knee-, ankle- or elbow bleeds for the next one year. The Cryo/Cuff protocol consisted of short applications (15 minutes) during the day, repeated every 1-2 hours. Outcomes included: Qualitative questionnaire to determine the perceived benefit or any adverse reactions to the device after 1-year use.
Key message: Reduced pain and swelling and no adverse effects with Cryo/Cuff treatment of haemarthroses in severe haemophilia.
Results:
• All patients reported that the application protocol was easy to follow, they were able to apply the device as per the PRICE regime and they were able to tolerate it for the recommended period. • All the patients felt that the device had a significant impact on alleviation of pain and return to pre-bleed status. • 78% of the patients felt that the device led to a significant reduction in swelling around the affected joint.
iEnovis
Pubmed
iEnovis
Pubmed
• No other adverse effects were reported by participants in this study.
• When asked to assess the overall perceived benefit in the management of knee-, ankle- or elbow haemarthroses, all patients either agreed or strongly agreed that the CryoCuff was beneficial to them compared with the year prior to the study when it had not been used.
40
© 2022 Enovis Corporation
CONFIDENTIAL
Made with FlippingBook - PDF hosting